4.5 Article

TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development

Journal

MOLECULAR IMMUNOLOGY
Volume 38, Issue 11, Pages 817-824

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0161-5890(02)00004-4

Keywords

monocyte differentiation; monocytic activation receptor complexes; TREM-1; MDL-1; DAP12; gene regulation

Funding

  1. NATIONAL CANCER INSTITUTE [U01CA080200] Funding Source: NIH RePORTER
  2. NCI NIH HHS [U01 CA080200] Funding Source: Medline

Ask authors/readers for more resources

The triggering receptor expressed on myeloid cells (TREM-1) and the myeloid DAP12-associating lectin (MIDL-1) are two recently identified receptors which associate non-covalently with DAP12 to form receptor complexes involved in monocytic activation and inflammatory response. In this study, we investigated whether the expression of TREM-1, MDL-1, and DAP12 correlated with myelomonocytic differentiation. Northern and RT-PCR revealed a strong expression of TREM-1, MDL-1, and DAP12 in peripheral blood-derived CD14(+) mature monocytes in contrast to undifferentiated bone marrow CD34(+) stem cells, and in the differentiated versus undifferentiated U937 cells. TREM-1 and MDL-1 RNA expression was also more elevated in adult than fetal tissues and in normal than malignant cells. These findings suggest that the TREM-1/DAP12 and MDL-1/DAP12 signaling pathways are features of mature differentiated myelomonocytic cells. In addition, expression of an alternative mRNA TREM-1 splice variant (TREM-1sv) was detected that might translate into a soluble receptor with potential as a regulator of myeloid activation. (C) 2002 Elsevier Science Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available